Weight Loss Injections in Liverpool: Facts, Not Myths

The biggest myth: that these are cosmetic treatments you can order like a supplement

The misconception comes up often, and it's understandable given how freely they're discussed online. The assumption goes: high demand, easy websites, so the medicines must be broadly available without much scrutiny. They are not. Mounjaro and Wegovy are prescription-only medicines regulated by the MHRA, and UK law is clear that a prescriber must assess your individual health before any supply is made. That assessment covers your BMI, your medical history, any medicines you already take, and conditions that would make these treatments unsuitable or unsafe for you specifically. A legitimate service does not skip that step. If you come across a seller offering these medicines without a clinical consultation, that is a red flag, not a shortcut — the MHRA's Yellow Card scheme allows anyone to report suspect sellers, and the agency has seized large quantities of fake pens in recent years. The medicine in a counterfeit pen may not be what it claims to be. Letting this myth go is genuinely useful, because it reframes the question: you're not looking for the easiest route, you're looking for a safe and clinically appropriate one.

What Liverpool residents can actually access, and through which routes

On the NHS in England, tirzepatide (Mounjaro) is being rolled out in phases. As of mid-2026, the current cohort requires a BMI of 40 or above plus four or more of five specified weight-related conditions: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease or type 2 diabetes. A second cohort, requiring a BMI of 35 to 39.9 with four or more of those conditions, became eligible in June 2026. Lower BMI thresholds apply for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds under UK clinical guidance. The NHS also commissions Wegovy through specialist weight management services under NICE guidance, though waiting lists in most areas remain lengthy. For the large majority of people in Liverpool who are interested in these treatments but do not meet those thresholds, or who do not want to wait, a private prescription route through a regulated medical weight loss service is the practical alternative. The licensed eligibility for private prescribing is broader: adults with a BMI of 30 or above, or 27 with a qualifying condition, may be considered, subject to a full clinical assessment. BMI alone is never the whole story, the prescriber looks at the complete picture. You can read more about who these medicines are and are not suitable for before starting.

Side effects, safety checks, and what a Liverpool-based patient should flag to their prescriber

The side-effect profile for both Mounjaro and Wegovy is well documented and largely gastrointestinal. Nausea is the most commonly reported experience, particularly in the first few weeks or after a dose increase; constipation, loose stools, indigestion and fatigue are also typical. For most people these settle as the body adjusts. The NHS tirzepatide page sets out the full list in plain language. One side effect that warrants more than passing mention is pancreatitis. In January 2026 the MHRA issued a Drug Safety Update confirming acute pancreatitis as a known, infrequent but serious risk: severe stomach pain that spreads to the back, with or without vomiting, needs urgent medical attention rather than a wait-and-see approach. Anyone with a history of pancreatitis, gallbladder disease, or certain gastrointestinal conditions should discuss this with their prescriber before starting. Pregnancy, breastfeeding and actively trying to conceive are clear contraindications, these medicines are not recommended in any of those situations, and anyone who becomes pregnant while on treatment should stop and speak to their GP or midwife promptly. Women using oral contraceptives who start tirzepatide should add a non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase, because pill absorption may be reduced; the equivalent concern has not been identified for semaglutide. If you have a history of liver disease, it is worth reading about how weight loss injections can affect your liver before speaking to your prescriber.

Choosing a registered provider: what that means in practice

Any pharmacy supplying prescription medicines to patients in the UK must be registered with the General Pharmaceutical Council. You can check any service using the GPhC's public register in a few seconds, enter the pharmacy's name or registration number and a live entry should appear. If it does not, walk away. Beyond registration, the practical markers of a legitimate service are a genuine clinical consultation with a named, qualified prescriber; identity and weight verification before treatment is approved; and a clear process for ongoing clinical review before each repeat. At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber the same day, your GP is notified in line with GPhC guidance, and your pen is dispatched the same day if clinically approved, arriving the next working day via tracked DPD delivery. You can explore how the delivery process works or take a look at how we're set up as a service. If you're ready to find out whether you're eligible, the next step is a free consultation with no obligation to proceed.